Biovail Hammers Watson Over Aplenzin ANDA
Asserting five patents for the antidepressant Aplenzin, Biovail Laboratories International SRL has launched a pair of infringement lawsuits seeking to prevent Watson Pharmaceuticals Inc. from bringing a generic version of the...To view the full article, register now.
Already a subscriber? Click here to view full article